← Back to Search

Task-Shifting Strategy for High Blood Pressure in HIV Care (TASSH NIMR Trial)

N/A

Waitlist Available

Led By Olugbenga Ogedegbe, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have a diagnosis of HTN with uncontrolled blood pressure, i.e. BP is 140-179/90-100 mm Hg.

Be an adult aged 18 years and older.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 months, 12 months, 18 months and 24 months

Awards & highlights

TASSH NIMR Trial Summary

This trial looks at how well a task-strengthening strategy for hypertension control works when integrated into primary health care for people living with HIV in Lagos, Nigeria.

Who is the study for?

This trial is for adults over 18 with HIV/AIDS who also have high blood pressure (140-179/90-100 mm Hg) and are receiving care at one of the 30 designated HIV clinics. It's not open to those with extremely high blood pressure, chronic kidney disease, heart disease, diabetes, stroke history, or pregnant individuals.Check my eligibility

What is being tested?

The study is testing a tailored-practice facilitation strategy called TASSH aimed at integrating hypertension management into existing HIV care services within primary health centers in Lagos, Nigeria.See study design

What are the potential side effects?

Since this trial involves a healthcare management strategy rather than a drug intervention, specific side effects related to medications are not applicable. However, there may be general risks associated with changes in healthcare practices.

TASSH NIMR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My blood pressure is high, between 140-179 over 90-100 mm Hg.

Select...

I am 18 years old or older.

Select...

My blood pressure is high, between 140-179 over 90-100.

TASSH NIMR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 months, 12 months, 18 months and 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 months, 12 months, 18 months and 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months, 18 months and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in systolic Blood Pressure

Secondary outcome measures

Change in Implementation Climate of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.

Change in Implementation Leadership of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.

Change in Organizational Readiness of Mediators of TASSH across the primary health centers (PHCs) at 12 and 24 months.

+5 more

TASSH NIMR Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: With Practice Facilitation (PF)Experimental Treatment1 Intervention

Participants will be identified from HIV clinics during routine visits and will receive the task-shifting strategy for HTN control (TASSH) protocol.

Group II: Self-directed without Practice Facilitation (PF)Active Control1 Intervention

Participants will be identified from HIV clinics during routine visits and provided standard of care.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,367 Previous Clinical Trials

838,931 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,833 Previous Clinical Trials

47,305,666 Total Patients Enrolled

Olugbenga Ogedegbe, MDPrincipal InvestigatorNYU Langone Health

1 Previous Clinical Trials

1,280 Total Patients Enrolled

Media Library

Task-shifting strategy for HTN control (TASSH) protocol Clinical Trial Eligibility Overview. Trial Name: NCT04704336 — N/A

High Blood Pressure Research Study Groups: Self-directed without Practice Facilitation (PF), With Practice Facilitation (PF)

High Blood Pressure Clinical Trial 2023: Task-shifting strategy for HTN control (TASSH) protocol Highlights & Side Effects. Trial Name: NCT04704336 — N/A

Task-shifting strategy for HTN control (TASSH) protocol 2023 Treatment Timeline for Medical Study. Trial Name: NCT04704336 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still the possibility to join this trial for individuals?

"The information on clinicaltrials.gov confirms that this medical trial is still recruiting participants. It was initially posted in September 2021 and has subsequently been revised up to November 2022."

Answered by AI

What type of research subject would be most suitable for this experiment?

"This medical trial requires the recruitment of 960 individuals aged 18 to 85 with a diagnosis of hypertension and uncontrolled blood pressure (i.e., BP 140-179/90-100 mm Hg). Furthermore, potential participants must visit one of 30 HIV clinics, demonstrate consenting capacity, and adhere to other specified conditions."

Answered by AI

What is the current sample size of individuals participating in this clinical investigation?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which was launched in September 13th 2021 is actively enrolling patients. The study needs to find 960 individuals from a single centre for participation purposes."

Answered by AI